Your browser doesn't support javascript.
loading
A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF.
Tumang, Joseph R; Holodick, Nichol E; Vizconde, Teresa C; Kaku, Hiroaki; Francés, Rubén; Rothstein, Thomas L.
Afiliação
  • Tumang JR; Immunobiology Laboratory, Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research Manhasset, NY, USA.
Front Immunol ; 2: 6, 2011.
Article em En | MEDLINE | ID: mdl-22566797
ABSTRACT
B1 B cells defend against infectious microorganisms by spontaneous secretion of broadly reactive "natural" immunoglobulin that appears in the absence of immunization. Among many distinguishing characteristics, B1 B cells display evidence of activation that includes phosphorylated STAT3. In order to identify the origin of pSTAT3 we examined interleukin-2 receptor (IL-2R) expression on B1 cells. We found that some (about 1/5) B1a cells express the IL-2R α chain, CD25. Although lacking CD122 and unresponsive to IL-2, B1a cells marked by CD25 express increased levels of activated signaling intermediates, interruption of which results in diminished CD25. Further, CD25⁺ B1a cells contain most of the pSTAT3 found in the B1a population as a whole. Moreover, CD25⁺ B1a cells express leukemia inhibitory factor receptor (LIFR), and respond to LIF by upregulating pSTAT3. Together, these results define a new subset of B1a cells that is marked by activation-dependent CD25 expression, expresses substantial amounts of activated STAT3, and contains a functional LIFR.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos